Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

Baricitinib effectively regrows hair in severe alopecia areata cases.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Non-immune factors play a significant role in alopecia areata.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Alopecia Areata might be linked to Crohn's disease.